Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis

被引：0
|
作者：
Li, Tingting [1 ,2 ,3 ]
Tao, Rong [4 ]
Yang, Li [1 ,2 ,3 ]
Wan, Zhe [1 ,2 ,3 ]
Li, Ruoyu [1 ,2 ,3 ]
Wang, Ruojun [1 ,2 ,3 ]
机构：
[1] Peking Univ First Hosp, Dept Dermatol, Beijing, Peoples R China
[2] Natl Clin Res Ctr Dermatol & Immunol Dis, Beijing, Peoples R China
[3] Peking Univ, Res Ctr Med Mycol, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tongren Hosp, Dept Dermatol, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2025年
关键词：
MGL-1304;
D O I：
10.1093/bjd/ljaf095
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Our study is the first to compare fungal microbiome changes in patients with atopic dermatitis (AD) before and after treatment with upadacitinib and dupilumab. We found that upadacitinib more effectively restores the fungal microbiome to levels observed in healthy individuals, which may contribute to its superior efficacy in head-and-neck dermatitis (a subtype of AD). The results enhance our understanding of how JAK inhibitors influence the skin microbiome in AD.
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real-World Study on Effectiveness and Safety in Dupilumab Nonresponders
    Zhao, Mutong
    Zhuang, Yi
    Liang, Yuan
    Ma, Lin
    Shen, Chunping
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (09): : 694 - 696
  • [32] Comparative effectiveness of upadacitinib versus dupilumab for moderate-to-severe atopic dermatitis: A retrospective cohort study
    Yang, Yan
    Chen, Jiaoquan
    Xiong, Siyin
    Zhang, Jing
    Ye, Qianru
    Xue, Rujun
    Tian, Xin
    Zhong, Jiemin
    Zhu, Huilan
    Gao, Aili
    Liu, Yumei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [33] Upadacitinib and Dupilumab Demonstrate Superior Efficacy in the Treatment of Adolescent Atopic Dermatitis: A Network Meta-Analysis
    Zhao, Zuotao
    Peng, Chengyue
    Liu, Lijuan
    Zheng, Yaqi
    Tan, Yen
    Song, Xiaoting
    Zhang, Peixin
    Huang, Xiaojie
    Zhang, Litao
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2025,
  • [34] Successful Treatment with Upadacitinib of Patient with Persistent Head and Neck Atopic Dermatitis Refractory to Dupilumab: A Case Report
    Park, So Yun
    Hong, Narang
    Kook, Hyung Don
    Lee, Dong Heon
    Jung, Hye Jung
    Park, Mi Youn
    Ahn, Jiyoung
    INDIAN JOURNAL OF DERMATOLOGY, 2024, 69 (02)
  • [35] Psoriasiform dermatitis induced by dupilumab successfully treated with upadacitinib
    Patruno, Cataldo
    Fabbrocini, Gabriella
    De Lucia, Mario
    Picone, Vincenzo
    Genco, Lucia
    Napolitano, Maddalena
    DERMATOLOGIC THERAPY, 2022, 35 (11)
  • [36] Microbiome in atopic dermatitis
    Wollina, Uwe
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2017, 10 : 51 - 56
  • [37] Changes in Skin and Nasal Microbiome and Staphylococcal Species Following Treatment of Atopic Dermatitis with Dupilumab
    Olesen, Caroline Meyer
    Ingham, Anna Cacilia
    Thomsen, Simon Francis
    Clausen, Maja-Lisa
    Andersen, Paal Skytt
    Edslev, Sofie Marie
    Yuksel, Yasemin Topal
    Guttman-Yassky, Emma
    Agner, Tove
    MICROORGANISMS, 2021, 9 (07)
  • [38] Conjunctivitis due to Dupilumab Treatment in Atopic Dermatitis: Clinical features and impact on gut microbiome
    Barry, Robert John
    Low, Liying
    Shamdas, Mohith
    Suleiman, Kusy
    Murad, Mariam
    Molloy, Kevin
    Velangi, Shireen
    Murray, Philip Ian
    Wallace, Graham R.
    Rauz, Saaeha
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [39] Effect of an emollient on the skin fungal microbiome of atopic dermatitis (AD) patients
    Chandra, J.
    Retuerto, M.
    Seite, S.
    Martin, R.
    Baron, E.
    Mukherjee, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S172 - S172
  • [40] The Usefulness of Atopic Dermatitis Control Tool in Upadacitinib Treatment for Patients with Atopic Dermatitis
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    DERMATOLOGIC THERAPY, 2024, 2024
12345